Switzerland found to be most innovative drug delivery market in Europe
According to new research, innovation in drug delivery is accelerating in Europe, with Switzerland as Europe’s biggest drug delivery innovator.
List view / Grid view
According to new research, innovation in drug delivery is accelerating in Europe, with Switzerland as Europe’s biggest drug delivery innovator.
Sir Andrew Dillion will be stepping down from his role as chief executive of NICE next year, after holding his position for 20 years.
Ningbo Huize Commodity Co has been sent a warning letter for cGMP violations, including data integrity issues.
Drug companies are still raising prices for brand-name prescription medicines but not as often or by as much as they used to.
Brüün has announced he will be leaving his role as CEO at the BPS and moving to a new role at the Royal College of Anaesthetists.
Sanofi has won the latest appeal for the patent of its top oncology product, Jevtana (cabazitaxel).
A complete response letter (CRL) has been sent to Dr Reddy’s for two generic products.
Pretomanid in combination with bedaquiline and linezolid has been approved by the FDA for treatment-resistant tuberculosis of the lungs.
Less than one-third of UK patient groups rate the reputation of the pharma industry as good or excellent.
The Philippines is considering re-introducing a dengue vaccine whose use was ceased because of links to several deaths.
New article says that to take full advantage of deep-learning solutions in healthcare, the US and China should collaborate, not compete.
A three-drug combination injection to treat patients with complicated urinary tract and intra-abdominal infections has been approved by the FDA.
The US Federal Trade Commission is investigating whether Johnson and Johnson violated antitrust laws with its medication, Remicade.
According to a new report, pharma companies in India are increasingly entering the Chinese pharma industry through joint ventures.
The pharmaceutical processing and packaging equipment market is expected to witness a high increase during the forecast period (2019-2025).